Comparative Study of Robotic, Laparoscopic and Open Surgery for Enucleation of Benign Pancreatic Neoplasms
- Conditions
- Pancreatic Neuroendocrine Tumors
- Interventions
- Procedure: Laparoscopic surgeryProcedure: Robotic surgeryProcedure: Open surgery
- Registration Number
- NCT02125929
- Lead Sponsor
- Peking Union Medical College Hospital
- Brief Summary
To determine the efficacy and safety of robotic, laparoscopic and open surgery for enucleation of benign pancreatic neuroendocrine tumors
- Detailed Description
The study was prospective and retrospective, non-randomized study included patients with benign pancreatic neoplasms. The robotic arm consecutively includes patients underwent robotic enucleation surgery and expected number in this arm is 50. The laparoscopic and open surgery arms retrospectively include case from the year 2004. The number of patients for laparoscopic and open surgery arms are 50 and 100, respectively.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 156
- 18-80 years old
- Body Mass Index<30
- Preoperative diagnosis of resectable benign Pancreatic Neuroendocrine Tumors
- Tumor type: Non-functional pancreatic endocrine tumours and insulinomas
- largest diameter < 4cm
- Preoperative CT showed no evidence that tumor was connected with main pancreatic duct
- Severe cardio/pulmonary complications
- Other pancreatic diseases, including pancreatitis and pancreatic cancer
- Multiple pancreatic neuroendocrine tumors
- Distant metastasis
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description Laparoscopic surgery Laparoscopic surgery laparoscopic surgery for enucleation benign Pancreatic Neuroendocrine Tumors Case number = 50 robotic arm Robotic surgery robotic surgery for enucleation benign Pancreatic Neuroendocrine Tumors Case number = 50 Open surgery Open surgery Open surgery for enucleation benign Pancreatic Neuroendocrine Tumors Case number = 100
- Primary Outcome Measures
Name Time Method Pancreatic fistula rate up to 30 days
- Secondary Outcome Measures
Name Time Method Mortality rate up to 30 days
Trial Locations
- Locations (1)
Department of General Surgery, Peking Union medical school hospital
🇨🇳Beijing, Beijing, China